The pharmaceutical industry imports in the US are forecasted to grow from 192.46 billion USD in 2024 to 237.37 billion USD by 2028. The sector saw imports totaling 180 billion USD in 2023. Year-on-year, the projected growth rates are as follows: 5.94% in 2025, 5.55% in 2026, 5.19% in 2027, and 4.89% in 2028. Over this five-year period, the compound annual growth rate (CAGR) stands at 5.39%. This indicates a robust and steady rise in imports.
Future trends to watch for include advancements in biotechnology, increased regulatory challenges, and potential impacts from geopolitical changes. These factors could either accelerate growth or introduce new risks to the import landscape.